ELV Elevance Health, Inc.

390.16USD-2.66%Mkt Cap: 84.30B USDP/E: 16.57

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Othe…

Institutional holders20 on file

Key Statistics

Company
Market Cap84.30B USD
Enterprise Value79.63B USD
Revenue (TTM)201.83B USD
Gross Profit53.35B USD
Net Income (TTM)5.66B USD
Revenue/Share923.29 USD
Last Price390.16 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees96.1K
CountryUS
SectorHealthcare
IndustryHealthcare Plans
ISIN—
Valuation
P/E (Trailing)16.57
P/E (Forward)12.88
PEG1.23
EV/EBITDA9.14
EV/Revenue0.39
P/S0.42
P/B1.89
EPS (TTM)23.55 USD
EPS (Forward)30.29 USD
52W Range
274.8466% of range450.69
52W High450.69 USD
52W Low274.84 USD
Profitability
Gross Margin26.43%
Oper. Margin3.98%
EBITDA Margin4.32%
Profit Margin2.84%
ROE12.90%
ROA4.66%
ROIC16.82%
ROCE—
Growth
Revenue Growth1.40%
Earnings Growth17.90%
Cash Flow & Leverage
Operating CF4.29B USD
CapEx (TTM)1.12B USD
FCF Margin3.96%
FCF Yield9.48%
Net Debt-7.09B USD
Net Debt/EBITDA-0.81
Net Debt/FCF-0.89
Balance Sheet
Debt/Equity0.73
Current Ratio1.47
Quick Ratio1.33
Book Value/Sh206.75 USD
Cash/Share175.17 USD
Dividends
Fwd Div Rate6.88 USD
Trail. Div Rate6.87 USD
Div. Yield1.72%
5Y Avg Yield1.31%
Payout Ratio29.17%
Ex-Div DateDec 4, 2026
Pay DateDec 18, 2026
Splits
Last Split2:1
Split DateJun 1, 2005
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)482.38 USD
Upside (mean)+23.6%
Target Range406.00 USD – 523.00 USD
406.00+23.6% to mean523.00
# Analysts21
Ownership
Shares Out.216.06M
Float215.57M
Insiders0.21%
Institutions94.12%
Short Interest
Short Ratio3.4d
Short % Float2.36%
Short % Out.2.10%
Shares Short4.54M
Short (prev mo.)4.85M
Technical
SMA 50416.17 (-6.3%)
SMA 200376.01 (+3.8%)
Beta0.63
S&P 52W Chg12.08%
Avg Vol (30d)1.47M
Avg Vol (10d)1.32M
Technical Indicators
RSI (14)36.3
MACD-0.8638
MACD Signal2.8799
MACD Hist.-3.7437
BB Upper449.98 USD
BB Middle423.83 USD
BB Lower397.68 USD
BB Width12.34%
ATR (14)14.89 USD
Vol Ratio (20d)1.99x

About Elevance Health (NYSE: ELV)

›

Elevance Health (NYSE: ELV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Healthcare Plans industry, part of the Healthcare sector, and reports about 96,129 employees.

The shares were at 390.16 USD on 19 November 2026, up 21.1% over 52 weeks. Its 52-week range is 274.84 USD to 450.69 USD: the price is 13.4% below the high and 42.0% above the low.

At a market capitalisation of 84.30B USD, it trades at 16.6 times trailing earnings and 12.9 times forward earnings. The median trailing P/E of its 9 largest Healthcare Plans peers is 22.5, a discount of 26% for ELV. It pays a dividend yielding 1.72% (it pays out 29% of its earnings), against a median of 2.42% among the dividend payers in that peer group.

Elevance Health reports return on equity of 12.9%, an operating margin of 4.0% and revenue up 1.4% year over year.

It holds more cash than debt, a net cash position of 7.09B USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 21 analysts cover the stock, with an average rating of Buy; their mean price target of 482.38 USD is 23.6% above the current price. The next earnings report is expected on 28 January 2027.